Vorinostat renders dormant HIV infection vulnerable to clearance
Wednesday, August 2, 2017 - 08:22
in Health & Medicine
An assay that can measure antigen production and clearance caused by a latency-reversing agent has now been developed for the first time by HIV researchers.